MedTrace Logo

Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners

NCT00503646 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2013-09-17

No results posted yet for this study

Summary

RATIONALE: Participating in a therapy program may enhance communication and intimacy between men with prostate cancer and their partners.

PURPOSE: This randomized clinical trial is studying how well therapy enhances communication and intimacy for men with early stage prostate cancer and for their partners.

Conditions

  • Prostate Cancer
  • Psychosocial Effects of Cancer and Its Treatment
  • Sexual Dysfunction and Infertility
  • Sexuality and Reproductive Issues

Interventions

OTHER

communication intervention

OTHER

counseling intervention

OTHER

questionnaire administration

PROCEDURE

psychosocial assessment and care

Sponsors & Collaborators

Principal Investigators

  • David W. Kissane, MD · Memorial Sloan Kettering Cancer Center

  • Christian J. Nelson, PhD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
RANDOMIZED

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2010-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00503646 on ClinicalTrials.gov